Bing Zhai
Impact in
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility
- Epidemiology top 5%
- Fungal Infections and Studies
- Nail Diseases and Treatments
Papers in
-
- Antifungal resistance and susceptibility 23
-
- Gut microbiota and health 7
- Co-authors
- Xiaorong Lin (9 shared papers)Linqi Wang (2 shared papers)Tobias M. Hohl (15 shared papers)Thierry Rolling (10 shared papers)Matthew S. Sachs (1 shared paper)Cheng Wu (1 shared paper)Nicholas L. Tosini (4 shared papers)Ying Taur (5 shared papers)
- Journals
- Journal of Molecular Liquids (3 papers)Molecular Immunology (3 papers)mBio (3 papers)Nature Medicine (2 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Bing Zhai
69 papers receiving 1.8k citations
Bing Zhai's Hit Papers
Peers
Comparison fields: 5 of 116
- Infectious Diseases 898
- Epidemiology 762
- Immunology 275
- Microbiology 80
- Applied Microbiology and Biotechnology 20
Countries citing papers authored by Bing Zhai
This map shows the geographic impact of Bing Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Zhai more than expected).
Fields of papers citing papers by Bing Zhai
This network shows the impact of papers produced by Bing Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Zhai. The network helps show where Bing Zhai may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Zhai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 212 | |
| 2 | 2019 | 171 | |
| 3 | 2012 | 148 | |
| 4 | Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap Hit paper breakdown → | 2023 | 125 |
| 5 | 2012 | 106 | |
| 6 | 2010 | 75 | |
| 7 | 2016 | 73 | |
| 8 | 2015 | 64 | |
| 9 | 2013 | 61 | |
| 10 | 2020 | 55 | |
| 11 | 2019 | 49 | |
| 12 | 2015 | 45 | |
| 13 | 2021 | 38 | |
| 14 | 2024 | 33 | |
| 15 | 2021 | 31 | |
| 16 | 2020 | 30 | |
| 17 | 2022 | 30 | |
| 18 | 2013 | 25 | |
| 19 | 2024 | 24 | |
| 20 | 2011 | 24 |
About Bing Zhai
Bing Zhai is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Immunology and Oncology, having authored 71 papers that have together received 1.8k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (23 papers), Fungal Infections and Studies (18 papers), Immunotherapy and Immune Responses (7 papers), Nail Diseases and Treatments (7 papers), Gut microbiota and health (7 papers), Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Infectious Diseases (898 citations), Epidemiology (762 citations), Immunology (275 citations), Microbiology (80 citations) and Applied Microbiology and Biotechnology (20 citations). Bing Zhai has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiaorong Lin, Linqi Wang, Tobias M. Hohl, Thierry Rolling, Matthew S. Sachs, Cheng Wu, Nicholas L. Tosini, Ying Taur, Srijana Upadhyay and Marcel R.M. van den Brink. Their work appears in journals such as Journal of Molecular Liquids, Molecular Immunology, mBio, Nature Medicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.